INTRODUCTION
============

*Acinetobacter* spp. are aerobic, glucose-nonfermenting gram-negative bacteria that are widely distributed in soil and water environments \[[@B1], [@B2]\]. Isolates belonging to the *A. calcoaceticus-A. baumannii* (Acb) complex of the genus *Acinetobacter* are important nosocomial pathogens. Finding an appropriate antimicrobial therapy against these pathogens is a serious concern. The prevalence of Acb complex-related infections has markedly increased in recent years \[[@B3], [@B4], [@B5]\]. The Acb complex is composed of *A. calcoaceticus*, *A. baumannii*, *A. pittii* (formerly known as *Acinetobacter* genospecies), and *A. nosocomialis* (formerly known as *Acinetobacter* genospecies), which are genetically and phenotypically related. With the exception of *A. calcoaceticus*, all members of the Acb complex are commonly associated with hospital-acquired infections, and they rapidly acquire diverse antimicrobial resistance determinants \[[@B6], [@B7]\].

In *Acinetobacter* spp., the acquisition and dissemination of an antimicrobial-resistant determinant is frequently facilitated by integrons \[[@B8]\]. Integrons contain integrase gene (*intI1*), the product of which facilitates site-specific acquisitions and removals of the gene cassettes contained in the integrons. Approximately 9-17% of the sequenced bacterial genomes harbor integrons, and integrons with the same organization and composition have been found in unrelated isolates in spatially and temporally distinct areas \[[@B9], [@B10]\]. In particular, class 1 integrons, which are characterized by two conserved segments, are the most widely disseminated isolate of *Acinetobacter* spp. Class 1 integrons harbor various antimicrobial resistance gene cassettes encoding broad-spectrum β-lactamase, dihydroflavonol-4-reductase (*dfr*), and aminoglycoside-modifying enzymes (AMEs), such as acetyltransferase (*aac*), adenylyltransferase (*aad*), and phosphotransferase (*aph*) \[[@B11], [@B12], [@B13], [@B14], [@B15]\]. Therefore, multidrug-resistant (MDR) *Acinetobacter* spp. harboring genetic elements are resistant to three or more classes of antimicrobial agents that contain quinolones, aminoglycosides, ampicillin-sulbactams, extended-spectrum cephalosporins, and carbapenems \[[@B16]\].

Genetic elements like integrons frequently transfer antimicrobial resistance determinants, and are widely disseminated among MDR *Acinetobacter* spp.; however, scarce data is available about the epidemiological characterization of integron-harboring bacteria. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR *Acinetobacter* spp. identified in a university hospital in Daejeon, Korea over a period of 7 yr. In addition, multilocus sequence typing (MLST) and repetitive extragenic palindromic sequence (REP)-PCR were performed to analyze the relationship between the integron types and MDR *Acinetobacter* isolates harboring integrons.

METHODS
=======

1. Bacterial isolates and *rpoB* gene analysis
----------------------------------------------

A total of 56 consecutive and MDR *Acinetobacter* isolates were collected from a university hospital laboratory in Daejeon, Korea between January 2006 and December 2012. *Acinetobacter* spp. were identified by using the Vitek 2 Automated Instrument ID System (bioMérieux; Marcy l\'Etoile, France) and by sequencing the partial *rpoB* housekeeping gene as described previously \[[@B17]\].

2. Antimicrobial agents and minimum inhibitory concentration (MIC) determinations
---------------------------------------------------------------------------------

The MICs of *Acinetobacter* isolates for amikacin, gentamicin, ceftazidime, cefepime, imipenem, meropenem, and ciprofloxacin were determined by the Epsiolon test (Etest; bioMérieux). The data were interpreted as per the criteria approved by CLSI \[[@B18]\]. *Escherichia coli* ATCC 25922 was used as a reference strain.

3. Characterization of integrons
--------------------------------

Multiplex PCR was used to detect class 1, 2, and 3 integrons \[[@B19]\]. All of the integron-positive isolates were subjected to PCR and sequencing assays using specific primers for the analysis of gene cassette arrays. Class 1 integrons were amplified by using primers hep58 (5\'-TCATGGCTTGTTATGACTGT-3\') and hep59 (5\'-GTAGGGCTTATTATGCACGC-3\'). Primers hep74 (5\'-CGGGATCCCGGACGGCATGCACGATTTGTA-3\') and hep51 (5\'-GATGCCATCGCAAGTACGAG-3\') were used to amplify class 2 integrons \[[@B20]\]. Whole-cell (genomic) DNA was obtained from each target strain by using a genomic DNA purification kit (SolGent; Daejeon, Korea) according to the manufacturer\'s instructions. For sequencing, PCR products were purified with a PCR purification kit (SolGent) according to the manufacturer\'s instructions. Sequencing was performed by using the BigDye Terminator Cycle Sequencing Kit (PE Applied Biosystems; Foster City, CA, USA) and the ABI PRISM 3730XL DNA Analyzer (PE Applied Biosystems). DNA fragments (up to 1 kb in size) were sequenced by using the overlapping PCR technique. The various DNA sequences were confirmed on the basis of the BLAST paired alignment facility (<http://blast.ncbi.nlm.gov>).

4. Molecular typing
-------------------

For isolates of *A. pittii* spp., a MLST scheme with 7 housekeeping genes (*cpn60*, *fusA*, *gltA*, *pyrG*, *recA*, *rplB*, and *rpoB*) was used to determine the sequence types (STs) \[[@B21]\]. On the other hand, the Oxford MLST scheme with 7 housekeeping genes (*cpn60*, *gdhB*, *gltA*, *gpi*, *gyrB*, *recA*, and *rpoD24*) was used to determine the STs of *A. baumannii* isolates \[[@B22]\]. Each ST number was assigned by comparing the allele sequences to those in the MLST databases (<http://www.pasteur.fr/mlst> and <http://pubmlst.org/abaumannii>).

In addition, epidemiological typing of isolates was performed by REP-PCR \[[@B23]\]. In the REP-PCR method, the primer pair of REP1 (5\'-III GCGCCGICATCAGGC-3\') and REP2 (5\'-ACGTCTTATCAGGCCTAC-3\') was used to amplify putative REP-like elements in the genomic DNA. Amplification reactions were performed in a final volume of 50 µL, containing 100 ng of chromosomal DNA, 5 µL of 10× Taq buffer, 1.0 µL of 10 mM deoxyribonucleoside 5\'-triphosphates (dNTPs) mix, 1.5 U of Taq DNA polymerase (SolGent), and 50 pmol of each primer. The cycling conditions were as follows: an initial denaturation step at 95℃ for 5 min followed by 30 cycles of 92℃ for 50 sec, 48℃ for 55 sec, and 70℃ for 5 min; and a final extension step at 70℃ for 10 min. The amplified products were separated via electrophoresis on 1.5% agarose gels containing ethidium bromide, and visualized by using the BioDoc-14TM Imaging system (UVP, Cambridge, UK).

RESULTS
=======

1. Identification of *Acinetobacter* spp.
-----------------------------------------

A total of 4 *Acinetobacter* spp. were identified: *A. baumannii* (N=30), *A. bereziniae* (N=4), *A. nosocomialis* (N=5), and *A. pittii* (N=17). The distribution of MICs for the 7 antimicrobial agents tested was similar among the 4 *Acinetobacter* isolates. Most of the *Acinetobacter* isolates showed high-level resistance to the antimicrobial agents, except for ciprofloxacin. MICs of ciprofloxacin were diverse, ranging from 0.19 mg/L to ≥32 mg/L ([Table 1](#T1){ref-type="table"}).

2. Characterization of class 1 integrons
----------------------------------------

Class 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types (types A, B, C, and D) on the basis of the gene cassette nucleotide sequence ([Table 1](#T1){ref-type="table"}). The 2.3-kb type A (*aacA4-catB8-aadA1*) was the most prevalent type but was detected only in *A. baumannii* isolates, except for one in an *A. bereziniae* isolate ([Table 2](#T2){ref-type="table"}). The 3.0-kb type B (*aacA4-bla*~IMP-1~*-bla*~OXA-2~) was detected in 3 *Acinetobacter* spp. (*A. bereziniae*, *A. nosocomialis*, and *A. pittii*). The 3.0-kb type C (*bla*~VIM-2~*-aacA7-aadA1*) and 1.8-kb type D (*aac3-1-bla*~OXA-2~*-orfD*) were detected only in *A. nosocomialis*.

3. Molecular typing
-------------------

The *A. baumannii* isolates were grouped by MLST into 6 distinct STs, including ST69 (1-46-3-2-2-58-3), ST75 (1-3-3-2-2-11-3), ST92 (1-3-3-2-2-7-3), ST137 (1-3-3-2-2-12-3), ST138 (1-3-3-2-2-50-3), and ST358 (1-3-3-2-2-145-3). ST138 (n=11) was the most prevalent ST, followed by ST137 (n=10). In this study, the *A. pittii* isolates were grouped by MLST into 4 distinct STs, including ST63 (17-20-23-10-20-13-20), ST119 (36-20-38-16-38-18-20), and the novel STs N-1 (44-20-46-10-20-18-20) and N-2 (44-21-46-10-20-18-20). Two of the 4 STs corresponded to single isolates, whereas ST63 and N-2 corresponded to 8 and 7 strains, respectively.

All *A. baumannii* and *A. pittii* isolates were typed by REP-PCR. Although most *A. baumannii* isolates displayed the same REP-PCR type regardless of the STs, *A. pittii* isolates showed diverse patterns depending on the STs ([Fig. 1](#F1){ref-type="fig"}).

DISCUSSION
==========

In recent years, dissemination of the antimicrobial resistance genes through integrons in *Acinetobacter* spp. has become a major focus in the treatment of nosocomial infections by MDR bacteria \[[@B13]\]. Class 1 integrons have been found to be prevalent in *Acinetobacter* clinical isolates worldwide, which contain diverse gene cassettes that encode resistance factors to antimicrobial agents such as aminoglycosides, broad-spectrum β-lactams, and trimethoprims \[[@B14]\]. Therefore, our study was designed to determine the prevalence of various class 1 integrons of MDR *Acinetobacter* spp. In addition, we analyzed the relationship between the class 1 integron gene cassette array and *Acinetobacter* spp.

Most of the MDR *Acinetobacter* isolates (89.3%) analyzed in this study harbored class 1 integrons, and the frequency of these isolates in the study region was considerably higher than that in other geographical regions, including the United Kingdom (60%) and China (74.9%) \[[@B24]\]. However, the prevalence of class 1 integrons among MDR *Acinetobacter* spp. is similar to that documented previously showing the occurrence of class 1 integrase gene in only 15 of 123 *Acinetobacter* isolates (12%), with all of these 15 isolates showing MDR \[[@B25]\]. The higher detection rate of class 1 integrons was probably due to the pre-selection of clinical isolates showing the MDR phenotype. Our results indicate that class 1 integron is widely disseminated among MDR *Acinetobacter* spp. in the university hospital in Daejeon, Korea.

According to our results, most MDR *Acinetobacter* spp. carry class 1 integrons, but the specific integron type varies depending on the species. Type A is the most prevalent class 1 integron detected in *Acinetobacter* isolates. However, of the 4 *Acinetobacter* species tested, only an isolate belonging to *A. baumannii* harbored type A, except for one *A. bereziniae* isolate. Twenty-five *A. baumannii* strains harboring type A were collected between 2007 and 2012, and all of the strains belonged to 6 STs (ST69, ST75, ST92, ST137, ST138, and ST358). Our results suggest that type A is a dominant type of integron and that it has been conserved for many years in *A. baumannii* and other *Acinetobacter* species. The type A gene cassette array has been reported in *A. baumannii* as well as in other bacteria, including *Acinetobacter* spp. (92.0%; 126/137), *Burkholderia cepacia* (22.2%; 2/9), *Klebsiella pneumonia* (4.8%; 4/83), and *E. coli* (0.6%; 1/164) \[[@B24], [@B26]\]. Although the type A detection rate was highest in *Acinetobacter* isolates, there is a relative paucity of data on the non-*A. baumannii Acinetobacter* isolates harboring type A. These earlier reports support our results that type A can usually be transmitted horizontally and vertically among *A. baumannii* isolates.

In contrast to type A, type B was amplified in *A. bereziniae*, *A. nosocomialis*, and *A. pittii* isolates, but not in *A. baumannii*. In particular, all *A. bereziniae* and *A. pittii* isolates contained type B, irrespective of the time sampled or the clone. This result was similar to that of previous studies that found type B in *A. pittii*, *A. bereziniae*, and *A. nosocomialis* strains isolated from Taiwan and South Korea \[[@B27], [@B28]\]. Our results suggest that type B can usually be transmitted across species among non-*A. baumannii Acinetobacter* isolates, and is conserved in the *Acinetobacter* isolates.

In this study, we performed MLST and REP-PCR for epidemiological typing of MDR *A. baumannii* and *A. pittii* isolates. The STs were not directly correlated with REP-PCR types in the *A. baumannii* isolates, but they were well correlated in *A. pittii* isolates. Previous studies have reported no correlation of STs with REP-PCR types, probably because of the REP-PCR methods used; however, the MLST results were correlated with the REP-PCR clusters \[[@B29], [@B30]\]. Further studies are required to confirm the relationship between REP-PCR and MLST types. On the other hand, we confirmed that *A. pittii* exhibited a diverse REP-PCR pattern, which was less clonal than that of *A. baumannii* showing the same REP-PCR pattern.

All class 1 integrons detected in our study contained aminoglycoside-resistance genes such as acetyltransferase (*aac*) and adenylyltransferase (*aad*), which have been typically found within integron gene cassette arrays \[[@B13]\]. All isolates harboring class 1 integrons showed a high-level resistance rate to aminoglycoside compounds such as amikacin and gentamicin. In addition, the class 1 integrons harbored β-lactamase genes (*bla*~OXA-2~, *bla*~IMP-1~, and *bla*~VIM-2~) and chloramphenicol-resistance gene (*catB8*). Consequently, the co-occurrence of several antimicrobial-resistance determinants via class 1 integrons can lead to the emergence of MDR *Acinetobacter* spp. In particular, type B and type C harboring metallo-β-lactamase (MBL) genes (*bla*~IMP-1~ and *bla*~VIM-2~) were detected in non-*A. baumannii Acinetobacter* isolates. These results suggest that a major mechanism of carbapenem resistance in non-*A. baumannii Acinetobacter* isolates involves class 1 integrons containing MBL genes. However, in this study, integrons containing carbapenemase genes were not detected in the *A. baumannii* isolates. This result suggests that acquisitions of class 1 integrons were not considered as major factors of carbapenem resistance in *A. baumannii* isolates. It has been reported that the carbapenem resistance of *A. baumannii* isolates is often associated with the presence of carbapenem-hydrolyzing class D β-lactamase (CHDL) genes located in chromosomes, plasmids, or transposons \[[@B31]\].

Despite the increasingly frequent discovery of MDR *Acinetobacter* isolates in Korea, not much information is available regarding the distributions of integrons of MDR *Acinetobacter* strains isolated in Daejeon, Korea. We confirmed that class 1 integrons harboring diverse gene cassettes are widely disseminated among MDR *Acinetobacter* isolates. Although class 1 integrons can be transferred horizontally between unrelated isolates belonging to different species, each type of the 4 gene cassette arrays evaluated in this study was found in isolates belonging to *Acinetobacter* spp., irrespective of the time sampled and STs. Our findings suggest that certain class 1 integrons tend to transfer horizontally and vertically among *A. baumannii* or non-*A. baumannii Acinetobacter* isolates. Accordingly, the present study emphasizes that continuous analyses of gene cassette arrays of class 1 integrons will provide useful information regarding antimicrobial resistance mechanisms specific to different *Acinetobacter* species.
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###### 

The MIC distribution of 7 antimicrobial agents for 56 MDR *Acinetobacter* spp. isolates
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^\*^Type A, *aacA4-catB8-aadA1*; Type B, *aacA4-bla*~IMP-1~*-bla*~OXA-2~; Type C, *bla*~VIM-2~*-aacA7-aadA1*; Type D, *aac3-1-bla*~OXA-2~*-orfD*.

Abbreviations: MIC, minimum inhibitory concentration; ST, sequence type; AMK, amikacin; GEN, gentamicin; CAZ, ceftazidime; FEP, cefepime; IPM, imipenem; MEM, meropenem; CIP, ciprofloxacin; N, novelsequence type.
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Gene cassette arrays obtained from MDR *Acinetobacter* isolates-*A. baumannii*, *A. bereziniae*, *A. nosocomialis*, and *A. pittii*

![](alm-34-293-i002)

Abbreviation: MDR, multidrug resistant.
